Bundoora, Australia

German Carlos Spangenberg

This inventor holds 51 USPTO granted patents and 39 published patent applications, plus 19 CIPO patents and 24 EPO patents, primarily in Plant Biotechnology. Top assignees: Agriculture Victoria Services Pty Limited, Dairy Australia Limited, Dow Agrosciences LLC. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: German Carlos Spangenberg. Retrieved from https://idiyas.com/inventor/german-carlos-spangenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 

% Patents Active = 60.8

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 133(Granted Patents)

Forward Citations (Not Self Cited) = 119(Dec 10, 2025)


Location History:

  • Bundoora, AU (2006 - 2023)
  • Victoria, AU (2023)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Endophytes
Flavonoid Biosynthesis
Gene Targeting
Plant Senescence
Lignin Biosynthesis
Metabolite Production
Transgene Integration
Symbiota Selection
Artificial Seeds
Plant Promoters
Haploid Selection
Organic Acid Biosynthesis
51 patents (USPTO):Explore Patents

Title: German Carlos Spangenberg: Pioneering Innovations in Endophytes and Plant Angiogenins

Introduction:

German Carlos Spangenberg, hailing from Bundoora, AU, is a prolific inventor and researcher renowned for his groundbreaking work in the field of plant biology. With an impressive portfolio of 49 patents, his contributions have significantly advanced our understanding of endophytes and plant-produced angiogenins. Let's delve into some of his latest patents, career highlights, collaborations, and the impact of his work.

Latest Patents:

Spangenberg's recent patents focus on two significant areas: endophytes and related methods, and angiogenin expression in plants. The first patent dives into the exploration of endophytes associated with plants within the-species complex, their influence on host plants, products derived from endophytes, and methods related to their study. This innovation opens up possibilities for harnessing the potential benefits of endophytes in various applications.

The second patent revolves around plant-produced angiogenins, their associated plant cells, plant calli, plants, seeds, and other plant parts. Spangenberg's work offers insights into the expression of angiogenin genes in plants, unveiling immense potential for therapeutic applications and further advancements in plant-based medicines.

Career Highlights:

Throughout his career, Spangenberg has held notable positions with Agriculture Victoria Services Pty Limited and Dow Agrosciences LLC (referred to as AgVic and Dow Agrosciences, respectively). Within these organizations, he has spearheaded numerous research projects, leading to valuable intellectual property and scientific breakthroughs. His dedication to pushing the boundaries of plant biology has opened up new avenues for commercial applications and scientific advancements.

Collaborations:

In his pursuit of innovation, Spangenberg has worked alongside remarkable colleagues, including Aidyn Mouradov and Timothy Ivor Sawbridge. These collaborations have fostered an environment conducive to knowledge exchange, pushing the boundaries of conventional research methodologies, and accelerating the development of groundbreaking inventions.

Conclusion:

German Carlos Spangenberg stands as a prominent figure in the realm of plant biology, having made remarkable contributions through his extensive patent portfolio. His research on endophytes and plant-produced angiogenins has laid the foundation for advancements in various industries, including agriculture, medicine, and biotechnology. As we anticipate further developments in these fields, Spangenberg's work will serve as a guiding light for future innovators and researchers seeking to explore the vast potential of nature's offerings.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…